Stock Price
1,251.70
Daily Change
-16.40 -1.29%
Monthly
2.64%
Yearly
-5.97%
Q3 Forecast
1,260.75

Dr.Reddys Laboratories reported INR85.45B in Sales Revenues for its fiscal quarter ending in June of 2025.




Sales Change Date
Aspen Pharmacare ZAR 21.96B 10.18B Dec/2024
Bharat Petroleum INR 1.3T 30B Jun/2025
Cipla INR 69.57B 2.27B Jun/2025
Dr.Reddys Laboratories INR 85.45B 390M Jun/2025
Sun Pharmaceuticals INR 138.51B 8.92B Jun/2025
UPL INR 94.3B 61.4B Jun/2025